Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Jan 7;2(1):27-36.
doi: 10.3233/BLC-150034.

Comparison of Guidelines on Non-Muscle Invasive Bladder Cancer (EAU, CUA, AUA, NCCN, NICE)

Nicholas E Power  1 , Jonathan Izawa  1
Affiliations
Free PMC article
Review

Comparison of Guidelines on Non-Muscle Invasive Bladder Cancer (EAU, CUA, AUA, NCCN, NICE)

Nicholas E Power et al. Bladder Cancer. .
Free PMC article

Abstract

Background: Non-muscle invasive bladder cancer (NMIBC) represents a considerably diverse patient group and the management of this complex disease is debatable. A number of panels from Europe and North America have convened on the topic and recently released guideline documents.

Objective: The purpose was to compare and contrast the NMIBC guideline recommendations from the EAU (Europe), CUA (Canada), NCCN (United States), AUA (United States), and NICE (United Kingdom).

Methods: All unabridged guideline documents were reviewed by the authors and comparisons were completed according to major topics in NMIBC.

Results: Despite a paucity of high level evidence regarding the majority of management topics in NMIBC, there was general agreement among the various guideline panels. Differences mainly centered on the categories of evidence synthesized and grades of recommendations. Each document offers a unique presentation of the available literature and guideline recommendation.

Conclusions: The guidelines for NMIBC from the EAU, CUA, AUA, NCCN, and NICE provide considerable consensus regarding the management of this often difficult disease. Clinicians are encouraged to familiarize themselves with all of the guidelines in order to determine which style of presentation would be most useful to their current practice.

Keywords: Canada; Europe; Guidelines; United States; bladder cancer; review.

PubMed Disclaimer

References

    1. Babjuk M BA, Burger M, Compérat E, Kaasinen E, Palou J, Rouprêt M, van Rhijn BWG, Shariat S, Sylvester R, Zigeuner R. EAU Guidelines on Non-muscle-invasive Bladder Cancer (Ta, T1 and CIS) 2015. https://uroweb.org/guideline/non-muscle-invasive-bladder-cancer/
    1. Witjes JA, Comperat E, Cowan NC, De Santis M, Gakis G, Lebret T, Ribal MJ, Van der Heijden AG, Sherif A. EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer 2015. https://uroweb.org/guideline/bladder-cancer-muscle-invasive-and-metastatic/ - PubMed
    1. Kassouf W TS, Kulkarni GS, Breau RH, Zlotta A, Fairey A, So A, Lacombe L, Rendon R, Aprikian AG, Siemens DR, Izawa JI, Black P. CUA guidelines on the management of non-muscle invasive bladder cancer. Can Urol Assoc J 2015;9(9-10):E690–E704. - PMC - PubMed
    1. Kassouf W, Kamat AM, Zlotta A, Bochner BH, Moore R, So A, Izawa J, Rendon RA, Lacombe L, Aprikian AG. Canadian guidelines for treatment of non-muscle invasive bladder cancer: A focus on intravesical therapy. Can Urol Assoc J 2010;4(3):168–173. - PMC - PubMed
    1. Hall MC CS, Dalbagni G, Pruthi RS, Schellhammer PF, Seigne JD, Skinner EC, Wolf JS. AUA Guideline for the Management of Nonmuscle Invasive Bladder Cancer: (Stages Ta,T1, and Tis): 2007 Update 2014. - PubMed

LinkOut - more resources